Table 2

The case fatality rate (CFR) of each comorbidity in patients hospitalised with influenza-like illness among the three age groups and all patients in Taiwan, 1 January 2005 to 31 December 2010

All patientsPaediatric patients (0–17 years)Adult patients (18–64 years)Elderly patients (≥65 years)
CFR (%)Diff (%)†OR (95% CI)CFR (%)Diff (%)†OR (95% CI)CFR (%)Diff (%)†OR (95% CI)CFR (%)Diff (%)†OR (95% CI)
Fatality rate in the group6.30.23.811.4
Comorbidities†
 Heart disease11.0+6.32.52 (2.38 to 2.66)*6.9+6.848.94 (20.97 to 114.19)*5.6+2.11.66 (1.42 to 1.93)*12.3+1.61.17 (1.10 to 1.25)*
 PVD13.3+7.12.32 (2.01 to 2.68)*0.0−0.29.3+5.52.63 (1.76 to 3.93)*14.2+2.91.30 (1.12 to 1.52)*
 Hypertension9.5+5.02.24 (2.11 to 2.36)*7.1+7.043.48 (9.94 to 190.24)*5.2+1.91.61 (1.41 to 1.84)*10.7−1.80.84 (0.78 to 0.89)*
 Hyperlipidaemia6.2−0.20.97 (0.88 to 1.07)0.0−0.23.4−0.40.89 (0.72 to 1.10)8.2−3.70.66 (0.59 to 0.74)*
 CVA11.6+6.72.51 (2.36 to 2.66)*9.1+8.958.18 (16.94 to 199.76)*7.1+3.72.19 (1.86 to 2.57)*12.6+1.91.20 (1.12 to 1.28)*
 Dementia/Epilepsy12.1+6.42.28 (2.12 to 2.45)*1.9+1.813.46 (6.32 to 28.69)*5.9+2.21.62 (1.27 to 2.08)*14.0+3.11.34 (1.24 to 1.44)*
 COPD/Asthma7.7+2.31.45 (1.37 to 1.53)*0.1−0.10.65 (0.27 to 1.55)4.2+0.61.17 (1.01 to 1.35)*10.2−3.00.75 (0.70 to 0.80)*
 Allergic rhinitis2.3−4.70.31 (0.27 to 0.35)*0.0−0.20.08 (0.01 to 0.62)*1.1−3.10.25 (0.18 to 0.35)*8.2−3.40.68 (0.59 to 0.79)*
 Autoimmune disease7.7+1.41.24 (0.92 to 1.66)0.0−0.24.8+1.01.27 (0.77 to 2.12)12.2+0.81.08 (0.75 to 1.56)
 Severe liver disease9.3+3.01.52 (1.02 to 2.27)*6.3+2.51.72 (0.98 to 3.03)16.9+5.51.58 (0.89 to 2.81)
 Peptic ulcer disease10.1+4.61.91 (1.79 to 2.04)*0.0−0.25.2+1.71.51 (1.29 to 1.76)*12.2+1.11.11 (1.04 to 1.20)*
 Diabetes10.6+5.32.10 (1.98 to 2.23)*0.0−0.26.6+3.42.13 (1.85 to 2.46)*12.0+0.91.09 (1.02 to 1.16)*
 Gout9.0+2.81.49 (1.34 to 1.66)*0.0−0.24.5+0.71.20 (0.93 to 1.57)10.9−0.50.95 (0.84 to 1.06)
 Hyperthyroidism7.6+1.21.21 (0.88 to 1.66)0.0−0.24.4+0.61.17 (0.67 to 2.04)11.7+0.31.03 (0.69 to 1.53)
 Hypothyroidism13.1+6.82.24 (1.75 to 2.87)*0.0−0.25.8+2.01.56 (0.82 to 2.95)17.9+6.51.70 (1.29 to 2.24)*
 CKD14.0+8.32.70 (2.51 to 2.92)*1.4+1.37.95 (1.07 to 58.78)*8.4+4.82.50 (2.04 to 3.05)*15.7+5.01.56 (1.43 to 1.69)*
 Cancer without metastasis12.9+7.82.75 (2.50 to 3.03)*6.7+6.553.79 (18.18 to 159.17)*8.2+6.03.91 (3.13 to 4.89)*15.0+4.81.55 (1.39 to 1.73)*
 Metastatic cancer19.9+14.84.64 (4.27 to 5.03)*5.9+5.847.07 (10.72 to 206.65)*17.8+15.69.48 (8.17 to 10.99)*21.8+11.62.46 (2.21 to 2.73)*
 Haematological malignancy14.9+9.83.25 (2.70 to 3.91)*3.4+3.326.52 (10.04 to 70.04)*14.1+11.97.18 (5.21 to 9.90)*19.2+9.02.10 (1.65 to 2.67)*
 Congenital immunodeficiency3.3−3.00.51 (0.07 to 3.74)0.0−0.214.3+10.54.24 (0.51 to 35.24)
 Organ transplantation4.1−2.30.62 (0.26 to 1.53)0.0−0.23.0−0.80.79 (0.25 to 2.48)10.5−0.90.91 (0.21 to 3.96)
 AIDS14.3+8.02.46 (1.21 to 4.99)*0.0−0.215.8+12.04.80 (2.35 to 9.81)*0.0−11.4
 Tuberculosis13.2+7.22.36 (2.11 to 2.62)*0.0−0.29.0+5.32.61 (2.00 to 3.40)*14.7+3.61.37 (1.22 to 1.55)*
 Mental illness6.9+0.51.09 (0.91 to 1.31)2.6+2.414.45 (1.93 to 108.12)*3.6−0.20.96 (0.70 to 1.30)14.0+2.71.27 (1.00 to 1.61)*
 Pregnancy/Post partum‡0.0−5.20.0−0.10.0−2.5
  • *P<0.05.

  • †The difference of CFR represented the value of CFR in patients with the index comorbidity minus the value of CFR in patients without the index comorbidity.

  • ‡Comparison between the females in each group.

  • CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; PVD, peripheral vascular disease.